Specific S100 Proteins Bind Tumor Necrosis Factor and Inhibit Its Activity
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms232415956
Abstract: Tumor necrosis factor (TNF) inhibitors (anti-TNFs) represent a cornerstone of the treatment of various immune-mediated inflammatory diseases and are among the most commercially successful therapeutic agents. Knowledge of TNF binding partners is critical for identification… read more here.
Keywords: tumor necrosis; specific s100; necrosis factor; s100 proteins ... See more keywords